Xencor Current Deferred Revenue from 2010 to 2024
XNCR Stock | USD 25.01 0.91 3.78% |
Check Xencor financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xencor's main balance sheet or income statement drivers, such as , as well as many indicators such as . Xencor financial statements analysis is a perfect complement when working with Xencor Valuation or Volatility modules.
Xencor |
About Xencor Financial Statements
Xencor shareholders use historical fundamental indicators, such as Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Xencor investors may analyze each financial statement separately, they are all interrelated. The changes in Xencor's assets and liabilities, for example, are also reflected in the revenues and expenses on on Xencor's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. Xencor, Inc. was incorporated in 1997 and is headquartered in Monrovia, California. Xencor operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 254 people.
Pair Trading with Xencor
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Xencor position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xencor will appreciate offsetting losses from the drop in the long position's value.Moving against Xencor Stock
0.66 | TCHH | Trustcash Holdings | PairCorr |
0.65 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.65 | MTEM | Molecular Templates | PairCorr |
0.65 | AGL | agilon health | PairCorr |
0.63 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Xencor could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Xencor when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Xencor - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Xencor Inc to buy it.
The correlation of Xencor is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Xencor moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Xencor Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Xencor can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Xencor Stock Analysis
When running Xencor's price analysis, check to measure Xencor's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xencor is operating at the current time. Most of Xencor's value examination focuses on studying past and present price action to predict the probability of Xencor's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xencor's price. Additionally, you may evaluate how the addition of Xencor to your portfolios can decrease your overall portfolio volatility.